ARCHIVES

In Brief: Hammer Reappointed chairman; Wyngaarden Names Ferguson of Baylor As OMAR Director

This article is from The Cancer Letter archive.

Vol. 14 No. 31 | July 29, 1988

Download PDF Visit The Full Archive

Related Articles

Report Tells NCI to Increase Funding for SPOREs.

June 30, 2006

VEGF Levels Can Predict Tumor’s Resistance to Avastin

July 29, 2011

B-27 Finds Improved CR For Taxotere Prior To Surgery

November 28, 2003

Three Community Based Programs Slated for Early Phaseout, Others Modified, Provided NCAB Agrees

February 29, 1980

Trombold Tells How Scripps Raises Money for Cancer Center, Gets Independent From “Whiny Administrator”

April 5, 1985

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976